Related references
Note: Only part of the references are listed.Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae
Giancarlo Ceccarelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
Helen Giamarellou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
Celine Vidaillac et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
Meredith G. Jernigan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
Phillip J. Bergen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates
Kyong Ran Peck et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan
Dror Marchaim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Multiplex PCR for detection of acquired carbapenemase genes
Laurent Poirel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes
Matthew E. Falagas et al.
FUTURE MICROBIOLOGY (2011)
Nitazoxanide Inhibits Biofilm Production and Hemagglutination by Enteroaggregative Escherichia coli Strains by Blocking Assembly of AafA Fimbriae
Eliah R. Shamir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Emerging carbapenemases: a global perspective
Timothy R. Walsh
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
Azza Elemam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones
Carlos Hernan Rodriguez et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2010)
Infection with Panresistant Klebsiella pneumoniae: A Report of 2 Cases and a Brief Review of the Literature
Azza Elemam et al.
CLINICAL INFECTIOUS DISEASES (2009)
Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection
Jooyun Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective
Maria Fernandez-Reyes et al.
PROTEOMICS (2009)
Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin
Miruna D. David et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
Neil Woodford et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii
DW Wareham et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii -: Reply
CM Urban et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections:: clinical outcome and adverse events
N Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents
S Bratu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient
A Thiolas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii
J Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
2003 report by the members of the French Society of Microbiology Antiobiogram Committee
G Carret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Can composition and structural features of oligonucleotides contribute to their wide-scale applicability as random PCR primers in mapping bacterial genome diversity?
AS Limansky et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2002)
Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York:: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage
VM Manikal et al.
CLINICAL INFECTIOUS DISEASES (2000)